HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Capromorelin

HCID 216208
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
193273-66-4
Standard SMILES
CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O
InChIKey
KVLLHLWBPNCVNR-SKCUWOTOSA-N
Molecular formula
C28H35N5O4
Average molar mass
505.6 g/mol
Monoisotopic mass
505.26890461

Overview

Capromorelin is under investigation in clinical trial NCT00527046 (Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited Adults).

Names & identifiers

Preferred name
Capromorelin
IUPAC
N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide
English name
Capromorelin
Molecular formula
C28H35N5O4
Molecular weight
505.61

Names & synonyms

Capromorelin193273-66-4CapimorelinCP-424391capromorelinacapromorelineCP-424,3910MQ44VUN84N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamideDTXSID5057886EluraN-((2R)-1-((3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo(4,3-c)pyridin-5-yl)-1-oxo-3-phenylmethoxypropan-2-yl)-2-amino-2-methylpropanamide
Show more names
391CP-424CS-1525CP-424391CP-424391, CapromorelinCaprimorelin (Capromorelin)N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-2H,3H,3aH,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-3-(benzyloxy)-1-oxopropan-2-yl]-2-amino-2-methylpropanamide
CAPROMORELINUMRefChem:57558DTXCID6031673Capromorelin [INN]CHEMBL113313Cp 424391UNII-0MQ44VUN84(3ar)-3a-benzyl-2-methyl-5-(2-methylalanyl-o-benzyl-d-seryl)-3-oxo-3,3a,4,5,6,7-hexahydro-2h-pyrazolo[4,3-c]pyridine

Database identifiers

CAS
193273-66-4
PubChem CID
216208
DTXSID
DTXSID5057886
ChEMBL
CHEMBL113313
UNII
0MQ44VUN84
Nikkaji
J1.233.873B

Properties

Computed structural properties

XLogP
1.1
Topological polar surface area
117 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
9
Heavy atoms
37
Formal charge
0
Complexity
878

Experimental & physicochemical properties

Animal DrugsFDA approved animal drugs -> Active ingredient

Physicochemical properties

Density
1.25 · 1.25
pka
15 · 15+-.0.46(Predicted)
FDA UNII
0 MQ44VUN84 · 0MQ44VUN84

Chemistry & industry

Pharmacology

ATC CodeQH - Systemic hormonal preparations, excl. sex hormones and insulin

Applications

UsesTreatment and prevention of frailty; treatment of congestive heart failure; treatment of catabolic illness (growth hormone secretagogue).

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes